Smart Money Brief | A $424M Buy, Selective Options Bets, and Tech Flow That Wouldn’t Quit

One biotech insider buy towered over the tape, options traders picked specific spots instead of spraying risk, and dark pool money stayed locked on semis and large-cap tech.